Skip to main content

Table 4 Echocardiographic parameters according to tertiles of circulating DPP4 activity in diabetic patients

From: The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

Parameters DPP4 (pmol/min/mL) p value
<5060 5060-6208 >6208
LV Morphology     
LVEDVindex (mL/m2) 63.7 ± 13 66.4 ± 12 63.9 ± 17 0.794
LVESVindex (mL/m2) 20.8 ± 6.6 22.9 ± 9.5 25.4 ± 7.7 0.080
IVSTd (mm) 10 (9-12) 11(9-13) 10 (9-12) 0.450
PWTd (mm) 10 (9-12) 11 (10-12) 11 (9.3-12) 0.095
RWT 0.42 ± 0.06 0.46 ± 0.05 0.42 ± 0.09 0.086
Prevalence of LV concentric geometry (n, %) 15, 55 20, 71 14, 50 0.128
LVM/BSA (g/m2) 94.6 (81-132) 112 (94.6-134) 110 (84-131) 0.201
Prevalence of LVH (n, %) 10, 37 16, 57 11, 40 0.294
Observed/predicted LVM (%) 124 ± 27.9 132 ± 25.4 134 ± 30.6 0.535
Prevalence of inappropriate LVM (n, %) 13, 48 16, 57 14, 50 0.932
LA Morphology     
LA long-axis (cm) 5.4 ± 0.7 5.1 ± 0.9 5.3 ± 0.8 0.443
LA minor-axis (cm) 4 ± 0.7 3.7 ± 0.7 3.9 ± 0.8 0.605
LA ap (cm) 3.8 ± 0.6 3.5 ± 0.9 3.8 ± 0.9 0.424
LA volume index (mL/m2) 20.3 (16-29.3) 17 (14.7-23.7) 20.7 (13.2-33) 0.450
Prevalence of LA enlargement (n,%) 7, 26 4, 14 8, 29 0.442
  1. LV means left ventricular; LVEDVi, LV end-diastolic volume index; LVESVi, LV end-systolic volume index; IVSTd, interventricular septum thickness in diastole; PWTd, posterior wall thickness in diastole; RWT, relative wall thickness; LVM, LV mass; BSA, body surface area; LVH, left ventricular hypertrophy; LA, left atrial. Values are expressed as mean ± SD or median (interquartile range), and categorical variables as numbers and percentages.